DexCom Financial Statements From 2010 to 2024
| D1EX34 Stock | BRL 9.38 0.08 0.86% |
Check DexCom financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DexCom's main balance sheet or income statement drivers, such as , as well as many indicators such as . DexCom financial statements analysis is a perfect complement when working with DexCom Valuation or Volatility modules.
DexCom |
DexCom Inc Company Operating Margin Analysis
DexCom's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current DexCom Operating Margin | 15.90 % |
Most of DexCom's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DexCom Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, DexCom Inc has an Operating Margin of 15.9%. This is 145.32% lower than that of the Healthcare sector and 125.09% lower than that of the Diagnostics & Research industry. The operating margin for all Brazil stocks is notably lower than that of the firm.
DexCom Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DexCom's current stock value. Our valuation model uses many indicators to compare DexCom value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DexCom competition to find correlations between indicators driving DexCom's intrinsic value. More Info.DexCom Inc is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.17 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for DexCom Inc is roughly 5.90 . Comparative valuation analysis is a catch-all model that can be used if you cannot value DexCom by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for DexCom's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About DexCom Financial Statements
DexCom stakeholders use historical fundamental indicators, such as DexCom's revenue or net income, to determine how well the company is positioned to perform in the future. Although DexCom investors may analyze each financial statement separately, they are all interrelated. For example, changes in DexCom's assets and liabilities are reflected in the revenues and expenses on DexCom's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in DexCom Inc. Please read more on our technical analysis and fundamental analysis pages.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. DEXCOM INC operates under Diagnostics Research classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 5500 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in DexCom Stock
When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:Check out the analysis of DexCom Correlation against competitors. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.